Literature DB >> 18301967

Suppressive effects of Anoectochilus formosanus extract on osteoclast formation in vitro and bone resorption in vivo.

Kikuko Masuda1, Mayumi Ikeuchi, Tomoyuki Koyama, Kohji Yamaguchi, Je-Tae Woo, Tomio Nishimura, Kazunaga Yazawa.   

Abstract

Anoectochilus formosanus, a plant native to Taiwan, is used as a folk medicine. It was found that oral administration of A. formosanus extract (AFE) (500 mg/kg) for 4 weeks suppressed bone weight loss and trabecular bone loss in ovariectomized mice, an experimental model of osteoporosis. Although AFE at 12.5 and 25 mug/ml inhibited osteoclast formation in co-culture of osteoblasts and bone marrow cells, AFE did not inhibit the formation of osteoclast progenitor cells and preosteoclast cells in bone marrow cells and RAW264 cells. However, AFE (at 12.5 and 25 microg/ml) decreased RANKL expression. These results suggested that AFE might suppress the bone loss caused by estrogen deficiency through suppression of RANKL expression required for osteoclast formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18301967     DOI: 10.1007/s00774-007-0810-8

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  21 in total

1.  Macrophage colony-stimulating factor suppresses osteoblast formation.

Authors:  M Gyda; S Corisdeo; M Zaidi; B R Troen
Journal:  Biochem Biophys Res Commun       Date:  2001-07-13       Impact factor: 3.575

Review 2.  Molecular mechanisms of bone resorption by the osteoclast.

Authors:  R Baron
Journal:  Anat Rec       Date:  1989-06

3.  Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

Authors:  H Hsu; D L Lacey; C R Dunstan; I Solovyev; A Colombero; E Timms; H L Tan; G Elliott; M J Kelley; I Sarosi; L Wang; X Z Xia; R Elliott; L Chiu; T Black; S Scully; C Capparelli; S Morony; G Shimamoto; M B Bass; W J Boyle
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

4.  Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.

Authors:  E Jimi; S Akiyama; T Tsurukai; N Okahashi; K Kobayashi; N Udagawa; T Nishihara; N Takahashi; T Suda
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

Review 5.  A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.

Authors:  N Takahashi; N Udagawa; T Suda
Journal:  Biochem Biophys Res Commun       Date:  1999-03-24       Impact factor: 3.575

6.  RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.

Authors:  N Nakagawa; M Kinosaki; K Yamaguchi; N Shima; H Yasuda; K Yano; T Morinaga; K Higashio
Journal:  Biochem Biophys Res Commun       Date:  1998-12-18       Impact factor: 3.575

7.  Antihyperglycaemic and anti-oxidant properties of Anoectochilus formosanus in diabetic rats.

Authors:  Chun-Ching Shih; Yueh-Wern Wu; Wen-Chuan Lin
Journal:  Clin Exp Pharmacol Physiol       Date:  2002-08       Impact factor: 2.557

8.  Transforming growth factor-beta induces osteoclast formation in the absence of RANKL.

Authors:  I Itonaga; A Sabokbar; S G Sun; O Kudo; L Danks; D Ferguson; Y Fujikawa; N A Athanasou
Journal:  Bone       Date:  2004-01       Impact factor: 4.398

9.  A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro.

Authors:  J M Quinn; J Elliott; M T Gillespie; T J Martin
Journal:  Endocrinology       Date:  1998-10       Impact factor: 4.736

10.  Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells.

Authors:  H Kodama; M Nose; S Niida; A Yamasaki
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  5 in total

1.  Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways.

Authors:  H-B Hsiao; H Lin; J-B Wu; W-C Lin
Journal:  Osteoporos Int       Date:  2012-11-10       Impact factor: 4.507

2.  Molecular cloning of a new immunomodulatory protein from Anoectochilus formosanus which induces B cell IgM secretion through a T-independent mechanism.

Authors:  Yen-Chou Kuan; Tsai-Jen Wu; Che-Yu Kuo; Ju-Chun Hsu; Wen-Ying Chang; Fuu Sheu
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

3.  Hepatoprotective Effects of Polysaccharide from Anoectochilus roxburghii (Wall.) Lindl. on Rat Liver Injury Induced by CCl4.

Authors:  Xiaoling Yu; Lingyi Huang; Chen You; Liying Huang
Journal:  Drug Des Devel Ther       Date:  2021-07-06       Impact factor: 4.162

4.  Potential antiosteoporotic agents from plants: a comprehensive review.

Authors:  Min Jia; Yan Nie; Da-Peng Cao; Yun-Yun Xue; Jie-Si Wang; Lu Zhao; Khalid Rahman; Qiao-Yan Zhang; Lu-Ping Qin
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-31       Impact factor: 2.629

5.  Potential anti-osteoporotic effects of herbal extracts on osteoclasts, osteoblasts and chondrocytes in vitro.

Authors:  Yoshiki Mukudai; Seiji Kondo; Tomoyuki Koyama; Chunnan Li; Seika Banka; Akiko Kogure; Kazunaga Yazawa; Satoru Shintani
Journal:  BMC Complement Altern Med       Date:  2014-01-17       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.